Business Context and Reporting Period
Company: American Healthcare REIT, Inc. (AHR)
Filing Type: Form 8-K (Current Report)
Date of Report: May 20, 2026
Event Date: May 22, 2026 (Closing of Offering)
Reporting Period: Specific event reporting regarding a capital raise transaction.
Key Financial Metrics and Transaction Details
- Capital Raised: Public offering of 14,000,000 shares of Common Stock ($0.01 par value).
- Underwriter: BofA Securities, Inc. (acting as Underwriter and Forward Seller).
- Forward Sale Structure: The company entered into a Forward Sale Agreement with an affiliate of the underwriter. The Forward Seller borrowed and sold 14,000,000 shares to hedge the Forward Purchaser's obligations.
- Settlement Terms: Physical settlement is intended to occur on dates specified by the company no later than May 20, 2028. The company will deliver shares in exchange for cash proceeds equal to the public offering price less the underwriting discount.
- Over-Allotment Option: The underwriter was granted a 30-day option to purchase up to 2,100,000 additional shares.
- Use of Proceeds: Net proceeds will be contributed to the Operating Partnership for general corporate purposes, including potential future investments.
- Financial Metrics: The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. It does not disclose the specific offering price per share or total gross proceeds.
Material Changes Versus Prior Period
This filing reports a discrete capital event rather than a comparative financial period. The material change is the execution of a forward sale agreement and the subsequent closing of a public offering of 14,000,000 shares, which will increase the company's share count upon settlement and provide liquidity for corporate purposes.
Guidance, Outlook, and Risks
- Management Commentary: The company intends to use net proceeds for general corporate purposes and potential future investments.
- Settlement Flexibility: The company retains the right to elect cash or net share settlement subject to certain conditions.
- Risks and Contingencies: The filing notes that representations and warranties in the Underwriting Agreement are not representations of factual information to investors regarding the company's condition. The settlement of the forward sale agreement is subject to the terms of the agreement and market conditions.
- Unusual Items: The transaction involves a forward sale structure where shares were borrowed and sold by the underwriter to hedge the forward purchaser's obligations, with the company settling the obligation up to two years later.
Investor Verification Checklist
- Verify the specific public offering price per share and total gross proceeds in the associated Prospectus Supplement (not included in this 8-K text).
- Confirm the exact settlement dates for the forward sale agreement, which are to be specified by the company but must occur by May 20, 2028.
- Review the Underwriting Agreement (Exhibit 1.1) and Forward Confirmation (Exhibit 1.2) for details on the underwriting discount and specific adjustments to the forward sale price.
- Monitor whether the underwriter exercises the option to purchase the additional 2,100,000 shares within the 30-day window.
- Check subsequent filings for the actual contribution of proceeds to the Operating Partnership and the specific allocation of funds for investments.